BML Capital Management, LLC
An institutional investment manager in ZIONSVILLE, IN. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 7, 2026. SEC CIK 1616824.
- Reported value$176.1m
- Positions18
Holdings: 18 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Aclaris Therapeutics IncACRS | COM | 00461U105 | 63.3 | 36.0% | 11,975,000 | Reduced−2,275,000 | |
| Atea Pharmaceuticals IncAVIR | COM | 04683R106 | 32.3 | 18.4% | 6,952,330 | Reduced−106,327 | |
| Engene Therapeutics IncENGN | COM *A* | 29286X101 | 11.5 | 6.6% | 6,669,908 | New+6,669,908 | |
| Kraft Heinz CoKHC | COM | 500754106 | 11.0 | 6.2% | 465,000 | Added+340,000 | |
| Outset Med IncOM | COM NEW | 690145206 | 10.9 | 6.2% | 2,519,701 | Added+617,500 | |
| Carmax IncKMX | COM | 143130102 | 9.1 | 5.2% | 172,500 | Added+17,500 | |
| Tillys IncTLYS | CL A | 886885102 | 9.0 | 5.1% | 2,150,000 | Unchanged | |
| PMV Pharmaceuticals IncPMVP | COM | 69353Y103 | 7.1 | 4.1% | 5,330,000 | Added+10,000 | |
| Instil Bio IncTIL | COM NEW | 45783C200 | 5.0 | 2.8% | 645,600 | Unchanged | |
| Target CorpTGT | COM | 87612E106 | 4.9 | 2.8% | 37,500 | Unchanged | |
| Oramed Pharmaceuticals IncORMP | COM NEW | 68403P203 | 4.2 | 2.4% | 866,269 | Reduced−2,300,962 | |
| Janux Therapeutics IncJANX | COM | 47103J105 | 2.4 | 1.4% | 154,961 | Unchanged | |
| Pliant Therapeutics IncPLRX | COM | 729139105 | 1.8 | 1.0% | 1,546,137 | Unchanged | |
| Connect Biopharma Holdings Ltd | SHS | G23549101 | 1.4 | 0.8% | 573,287 | Added+164,400 | |
| Imagenebio IncIMA | COM | 45175G207 | 1.2 | 0.7% | 200,730 | Unchanged | |
| Walmart IncWMT | COM | 931142103 | 0.4 | 0.2% | 335 | Put | Unchanged |
| Core Scientific Inc NewCORZ | COM | 21874A106 | 0.3 | 0.2% | 800 | Put | New+800 |
| Tesla IncTSLA | COM | 88160R101 | 0.3 | 0.2% | 375 | Put | New+375 |
Sold out: 1 position
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Kezar Life Sciences Inc | COM NEW | 49372L209 | 0.0 | 0.0% | 0 | Sold out−720,787 |
Source: SEC EDGAR, Form 13F-HR, accession 0001754960-26-000696 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.